Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hans J. Möbius"'
Autor:
Hans J. Möbius
Publikováno v:
International Journal of Geriatric Psychiatry. 18:S47-S54
Nine years after the initial approval of a cholinergic drug for the treatment of Alzheimer's Disease in the USA, a compound with a different pharmacological approach, namely the NMDA antagonist memantine, has been approved for the first time in Europ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::015d4995984b44ccf15acf748dc1d66e
https://doi.org/10.1002/gps.939
https://doi.org/10.1002/gps.939
Autor:
Ricardo F. Allegri, H. Michael Arrighi, Pablo M. Bagnati, Menghis Bairu, Sonia Brucki, Tal Burt, Lorne Cheeseman, Richard Chin, Debbie N. Cote, Jeffrey Cummings, Stephanie Danandjaja, P. Murali Doraiswamy, Murat Emre, James (Dachao) Fan, Yoko Fujimoto, Michel Grothe, Ibrahim Hakan Gürvit, Spencer Guthrie, Harald Hampel, Lynne Hughes, Michael Hüll, Hilal İlbars, Takeshi Iwatsubo, Roy W. Jones, Nadina C. Jose, Amir Kalali, Seong Yoon Kim, Miia Kivipelto, Bernd J. Krause, Jens Kurth, Huafang Li, Francesca Mangialasche, Hans J. Möbius, Ricardo Nitrini, Tiia Ngandu, Muriel O’Byrne, Peter Schüler, Klaudius Siegfried, Sidney A. Spector, Stefan Teipel, Yağiz Üresin, Michael Weiner, Jing Yin, Xue (Kate) Zhong
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ddf95cb08be205d45de9a3c12a30420
https://doi.org/10.1016/b978-0-12-411464-7.00027-4
https://doi.org/10.1016/b978-0-12-411464-7.00027-4
Autor:
Hans J. Möbius
Regulatory approval of the first rational AD therapeutic tacrine occurred in 1993, followed by the approval of three other, AChEIs, and the NMDA antagonist memantine in 2002 (EMA) and 2003 (FDA) respectively. Since then, despite an enormous research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05d1c9320ed0c539c8be67fa4b799650
https://doi.org/10.1016/b978-0-12-411464-7.00007-9
https://doi.org/10.1016/b978-0-12-411464-7.00007-9